10/15/25, 7:01 PM

NCD - Induced Lesions of Nerve Tracts (160.1)

National Coverage Determination (NCD)

Induced Lesions of Nerve Tracts

160.1

Links in PDF documents are not guaranteed to work. To follow a web link, please use the MCD

Website.

Tracking Information

Publication Number

100-3

Manual Section Number

160.1

Manual Section Title

Induced Lesions of Nerve Tracts

Version Number

1

Effective Date of this Version

This is a longstanding national coverage determination. The effective date of this version has not been posted.

Description Information

Beneﬁt Category

Physicians' Services

Please Note: This may not be an exhaustive list of all applicable Medicare beneﬁt categories for this item or service.

Indications and Limitations of Coverage

Surgically induced lesions of nerve tracts which involve destruction of nerve tissue are primarily indicated for controlling the chronic or acute pain arising from conditions such as

terminal cancer or lumbar degenerative arthritis. Induced lesions of nerve tracts may be produced by surgical cutting of the nerve (rhizolysis), chemical destruction of the nerve, or by creation of a radio-frequency lesion (electrocautery). Accordingly, program payment may be

https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=19&NCDver=1

1/2

10/15/25, 7:01 PM

NCD - Induced Lesions of Nerve Tracts (160.1)

made for these denervation procedures when used in selected cases (concurred in by the

Medicare Administrative Contractor’s medical staff) to treat chronic pain.

Note that these procedures differ from those employing implanted electrodes and

associated equipment to control pain in that the nerve ﬁbers are ablated rather than

stimulated and no electronic equipment is required by the patient after the operation.

Additional Information

Other Versions

Title

Version

Effective Between

Induced Lesions of Nerve Tracts

1

01/01/1966 - N/A

You are here

https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=19&NCDver=1

2/2